Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12725)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 25, 2021 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Santos Apolonio J, Lima de Souza Gonçalves V, Cordeiro Santos ML, Silva Luz M, Silva Souza JV, Rocha Pinheiro SL, de Souza WR, Sande Loureiro M, de Melo FF. Oncolytic virus therapy in cancer: A current review. World J Virol 2021; 10(5): 229-255 [PMID: 34631474 DOI: 10.5501/wjv.v10.i5.229] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i5/229.htm |
| Number | Citing Articles |
| 1 |
Trisha I. Valerio, Coline L. Furrer, Negar Sadeghipour, Sophia-Joy X. Patrock, Sayre A. Tillery, Ashley R. Hoover, Kaili Liu, Wei R. Chen. Immune modulations of the tumor microenvironment in response to phototherapy. Journal of Innovative Optical Health Sciences 2023; 16(03) doi: 10.1142/S1793545823300070
|
| 2 |
Izzet Altun, Yusuf M. Demirlenk, Dila Atar, Enes Cevik, Seyda Gunduz, Hassan Albadawi, Rahmi Oklu. Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies. Journal of Vascular and Interventional Radiology 2024; 35(2): 164 doi: 10.1016/j.jvir.2023.10.009
|
| 3 |
Juri Na, Chul-Hee Lee, June-Key Chung, Hyewon Youn. Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression. International Journal of Molecular Sciences 2023; 24(3): 2761 doi: 10.3390/ijms24032761
|
| 4 |
Jan Sören Eichhorn, Jim Petrik. The tumor microenvironment’s in pancreatic cancer: Effects on immunotherapy success and novel strategies to overcome the hostile environment. Pathology - Research and Practice 2024; 259: 155370 doi: 10.1016/j.prp.2024.155370
|
| 5 |
Saru Basnet, Joao M. Santos, Dafne C.A. Quixabeira, James H.A. Clubb, Susanna A.M. Grönberg-Vähä-Koskela, Victor Arias, Santeri Pakola, Tatiana V. Kudling, Camilla Heiniö, Riikka Havunen, Victor Cervera-Carrascon, Suvi Sorsa, Marjukka Anttila, Anna Kanerva, Akseli Hemminki. Oncolytic adenovirus coding for bispecific T cell engager against human MUC-1 potentiates T cell response against solid tumors. Molecular Therapy - Oncolytics 2023; 28: 59 doi: 10.1016/j.omto.2022.12.007
|
| 6 |
Muhammad Ikrama, Muhammad Usama. Oncolytic virotherapy in gastric cancer: Towards precision therapeutics. Gastroenterology & Endoscopy 2024; 2(2): 79 doi: 10.1016/j.gande.2024.03.006
|
| 7 |
Roderick C. McDowell, Jordhan D. Booth, Allyson McGowan, Wojciech Kolodziejczyk, Glake A. Hill, Santanu Banerjee, Manliang Feng, Karina Kapusta. Computational Approach for the Development of pH-Selective PD-1/PD-L1 Signaling Pathway Inhibition in Fight with Cancer. Cancers 2024; 16(13): 2295 doi: 10.3390/cancers16132295
|
| 8 |
Hao Lin, Chaxian Liu, Ankang Hu, Duanwu Zhang, Hui Yang, Ying Mao. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. Journal of Hematology & Oncology 2024; 17(1) doi: 10.1186/s13045-024-01544-7
|
| 9 |
Daniel Sausen, Oren Shechter, Elisa Gallo, Harel Dahari, Ronen Borenstein. Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications. Cancers 2023; 15(14): 3692 doi: 10.3390/cancers15143692
|
| 10 |
Yan-Ruide Li, Zibai Lyu, Yanxin Tian, Ying Fang, Yichen Zhu, Yuning Chen, Lili Yang. Advancements in CRISPR screens for the development of cancer immunotherapy strategies. Molecular Therapy - Oncolytics 2023; 31: 100733 doi: 10.1016/j.omto.2023.100733
|
| 11 |
Arianna Mayorga-Ramos, Johana Zúñiga-Miranda, Saskya E. Carrera-Pacheco, Carlos Barba-Ostria, Linda P. Guamán. CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance. ACS Infectious Diseases 2023; 9(7): 1283 doi: 10.1021/acsinfecdis.2c00649
|
| 12 |
Saurabh Gautam, Dongyue Xin, Alan Pardo Garcia, Bart Spiesschaert. Single-step rapid chromatographic purification and characterization of clinical stage oncolytic VSV-GP. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.992069
|
| 13 |
Sandra Pelka, Chandan Guha. Enhancing Immunogenicity in Metastatic Melanoma: Adjuvant Therapies to Promote the Anti-Tumor Immune Response. Biomedicines 2023; 11(8): 2245 doi: 10.3390/biomedicines11082245
|
| 14 |
Nikita Mundhara, Pritam Sadhukhan. Cracking the Codes behind Cancer Cells’ Immune Evasion. International Journal of Molecular Sciences 2024; 25(16): 8899 doi: 10.3390/ijms25168899
|
| 15 |
Zinnia P. Parra‐Guillen, Aymara Sancho‐Araiz, Kapil Mayawala, Sara Zalba, Maria J. Garrido, Dinesh de Alwis, Iñaki F. Troconiz, Tomoko Freshwater. Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically‐Based Modeling. Clinical Pharmacology & Therapeutics 2023; 114(3): 623 doi: 10.1002/cpt.2937
|
| 16 |
Chun Fang Shen, Elodie Burney, Rénald Gilbert, S. Mehdy Elahi, Kelley Parato, Martin Loignon. Development, optimization, and scale‐up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus‐1. Biotechnology Journal 2024; 19(1) doi: 10.1002/biot.202300244
|
| 17 |
Sabrina DeStefano, Daphna Fertil, Mondreakest Faust, Kaitlyn Sadtler. Basic immunologic study as a foundation for engineered therapeutic development. Pharmacology Research & Perspectives 2024; 12(4) doi: 10.1002/prp2.1168
|
| 18 |
Anurag S. Rathore, Narendra Chirmule, Rozaleen Dash, Anandi Chowdhury. Immunology for Engineers. Advances in Protein Chemistry and Structural Biology 2024; 140: 293 doi: 10.1016/bs.apcsb.2023.12.006
|
| 19 |
Anita Silas La’ah, Shih-Hwa Chiou. Cutting-Edge Therapies for Lung Cancer. Cells 2024; 13(5): 436 doi: 10.3390/cells13050436
|
| 20 |
Bo-Kyoung Jung, Yong Hee An, Sung Hoon Jang, Jin-Ju Jang, Seonhee Kim, Joo Hee Jeon, Jinju Kim, Jason Jungsik Song, Hyun Jang. The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect. Virology Journal 2024; 21(1) doi: 10.1186/s12985-023-02276-9
|
| 21 |
|
| 22 |
Kaoutar Bentayebi, Rim El Aked, Oumaima Ezzahidi, Alae Bekkouri Alami, Sara Louati, Mouna Ouadghiri, Tarik Aanniz, Saaïd Amzazi, Lahcen Belyamani, Azzedine Ibrahimi, Keittisak Suwan, Amin Hajitou, Rachid Eljaoudi. Targeting molecular mechanisms underlying treatment efficacy and resistance in DIPG: A review of current and future strategies. Brain Disorders 2024; 14: 100132 doi: 10.1016/j.dscb.2024.100132
|
| 23 |
Vahideh Hamidi-Sofiani, Reza Rakhshi, Niloufar Moradi, Parisa Zeynali, Mohsen Nakhaie, Emad Behboudi. Oncolytic viruses and pancreatic cancer. Cancer Treatment and Research Communications 2022; 31: 100563 doi: 10.1016/j.ctarc.2022.100563
|
| 24 |
Lin Fang, Weiping Tian, Chen Zhang, Xueyan Wang, Wanjing Li, Qi Zhang, Yuxin Zhang, Junnian Zheng. Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma. Pharmacological Research 2023; 189: 106701 doi: 10.1016/j.phrs.2023.106701
|
| 25 |
|
| 26 |
Geng-Hao Bai, Sheng-Chieh Lin, Yi-Hsiang Hsu, Shih-Yen Chen. The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications. Viruses 2022; 14(2): 278 doi: 10.3390/v14020278
|
| 27 |
Federica Li Pomi, Francesco Borgia, Paolo Custurone, Mario Vaccaro, Giovanni Pioggia, Sebastiano Gangemi. Role of HMGB1 in Cutaneous Melanoma: State of the Art. International Journal of Molecular Sciences 2022; 23(16): 9327 doi: 10.3390/ijms23169327
|
| 28 |
Maryam Sadri, Alireza Najafi, Ali Rahimi, Nafiseh Behranvand, Mohammad Hossein Kazemi, Hossein Khorramdelazad, Reza Falak. Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?. International Immunopharmacology 2023; 122: 110470 doi: 10.1016/j.intimp.2023.110470
|
| 29 |
Estanislao Nistal-Villan, Sergio Rius-Rocabert, Francisco Llinares-Pinel. Viral Vectors in Cancer Immunotherapy. International Review of Cell and Molecular Biology 2023; 379: 221 doi: 10.1016/bs.ircmb.2023.05.004
|
| 30 |
Zizhao Mai, Yunfan Lin, Pei Lin, Xinyuan Zhao, Li Cui. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death & Disease 2024; 15(5) doi: 10.1038/s41419-024-06697-4
|
| 31 |
Ela Guo, Hana M. Dobrovolny. Mathematical Modeling of Oncolytic Virus Therapy Reveals Role of the Immune Response. Viruses 2023; 15(9): 1812 doi: 10.3390/v15091812
|
| 32 |
Qing Ji, Yuchen Wu, Andreas Albers, Meiyu Fang, Xu Qian. Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches. Pharmaceutics 2022; 14(9): 1811 doi: 10.3390/pharmaceutics14091811
|
| 33 |
Luying Pan, Johanna Mora, Karl Walravens, Leslie Wagner, Shirley Hopper, Lina Loo, David Bettoun, Sarah Bond, Francis Dessy, Sean Downing, Fabio Garofolo, Soumi Gupta, Neil Henderson, Chad Irwin, Akiko Ishii-Watabe, Sumit Kar, Vibha Jawa, Julie Joseph, Ludovic Malvaux, Jean-Claude Marshall, Jessica McDevitt, Susovan Mohapatra, Jessica Seitzer, Justin Smith, Therese Solstad, Hiroshi Sugimoto, Omar Tounekti, Bonnie Wu, Yuling Wu, Yuanxin Xu, Joshua Xu, Takenori Yamamoto, Lin Yang, Albert Torri, Susan Kirshner, Kimberly Maxfield, Joao Pedras Vasconcelos, Mohsen Rajabi Abhari, Daniela Verthelyi, Eric Brodsky, Montserrat Carrasco-Triguero, John Kamerud, Matthew Andisik, Daniel Baltrukonis, Nicoletta Bivi, Isabelle Cludts, Kelly Coble, Boris Gorovits, George R Gunn, Swati Gupta, Anders Holm Millner, Alison Joyce, Robert J Kubiak, Seema Kumar, Karen Liao, Mohanraj Manangeeswaran, Michael Partridge, Samuel Pine, Johann Poetzl, Manoj Rajadhyaksha, Michele Rasamoelisolo, Susan Richards, Yuan Song, Steven Swanson, Seth Thacker, Meenu Wadhwa, Andreas Wolf, Lucia Zhang, Lin Zhou.
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, Ada Affinity, Risk-Based Approaches, Ngs, Qpcr, Ddpcr Assays (
Part 3
– Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Immunogenicity & Risk Assessment of Biotherapeutics and Novel Modalities; NAb Assays Integrated Approach)
. Bioanalysis 2023; 15(14): 773 doi: 10.4155/bio-2023-0135
|
| 34 |
Kay Hänggi, Brian Ruffell. Cell death, therapeutics, and the immune response in cancer. Trends in Cancer 2023; 9(5): 381 doi: 10.1016/j.trecan.2023.02.001
|
| 35 |
Shanying Huang, Haiyan Hu, Guoling Tang, Kai Liu, Zhihua Luo, Weiwei Zeng. An oncolytic herpes simplex virus type 1 strain expressing a single-chain variable region antibody fragment against PD-1 and a PI3K inhibitor synergize to elicit antitumor immunity in ovarian cancer. Archives of Virology 2023; 168(4) doi: 10.1007/s00705-023-05754-1
|
| 36 |
Samriti Dhawan, Vishal Sharma, Jagdeep Kaur. Molecular Biomarkers for Cancer Diagnosis and Therapy. 2024; : 537 doi: 10.1007/978-981-99-3746-2_26
|
| 37 |
Jingyu Zhang, Jiahe Chen, Kezhi Lin. Immunogenic cell death-based oncolytic virus therapy: A sharp sword of tumor immunotherapy. European Journal of Pharmacology 2024; 981: 176913 doi: 10.1016/j.ejphar.2024.176913
|
| 38 |
Thi Kim Anh Nguyen, Huu-Thinh Nguyen, Sao-Mai Dam. Cancer Treatment: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 2: 47 doi: 10.1007/16833_2023_135
|
| 39 |
Palaniyandi Muthukutty, So Young Yoo. Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective. Viruses 2023; 15(8): 1645 doi: 10.3390/v15081645
|
| 40 |
Junhe Zhang, Yunxi Xiao, Jie Zhang, Yun Yang, Liao Zhang, Fan Liang. Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-023-04817-w
|
| 41 |
Assia Angelova, Milena Barf, Alexandra Just, Barbara Leuchs, Jean Rommelaere, Guy Ungerechts. H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma. Cancers 2024; 16(15): 2711 doi: 10.3390/cancers16152711
|
| 42 |
Wenmo Liu, Xupu Wang, Xinyao Feng, Jiahao Yu, Xinyao Liu, Xinyuan Jia, Haihong Zhang, Hui Wu, Chu Wang, Jiaxin Wu, Bin Yu, Xianghui Yu. Oncolytic adenovirus-mediated intratumoral expression of TRAIL and CD40L enhances immunotherapy by modulating the tumor microenvironment in immunocompetent mouse models. Cancer Letters 2022; 535: 215661 doi: 10.1016/j.canlet.2022.215661
|
| 43 |
Mohamed E. Elnosary, Fatma K. Salem, Omar Mohamed, Mahmoud A. Elbas, Adel A. Shaheen, Magdy T. Mowafy, Ibrahim E. Ali, Aya Tawfik, Ahmed A. Hmed, Ehab E. Refaey, Esmat M. Esmat, Ahmed R. Sofy. Unlocking the potential: a specific focus on vesicular stomatitis virus as a promising oncolytic and immunomodulatory agent in cancer therapy. Discover Medicine 2024; 1(1) doi: 10.1007/s44337-024-00082-y
|
| 44 |
Hui Ma, Qing-Zhu Yan, Jing-Ru Ma, Dong-Fu Li, Jun-Ling Yang. Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies. World Journal of Gastroenterology 2024; 30(10): 1295-1312 doi: 10.3748/wjg.v30.i10.1295
Abstract(360) |
Core Tip(354) |
Full Article(HTML)(1752)
|
Full Article with Cover (PDF)-1506K(110)
|
Full Article (Word)-897K(0)
|
Audio-407K(3)
|
Peer-Review Report-310K(38)
|
Answering Reviewers-316K(38)
|
Full Article (PDF)-1251K(136)
|
Full Article (XML)-349K(40)
|
Times Cited (0)
|
Total Visits (3765)
|
Open
|
| 45 |
Thomas Karadimas, Thien Huong Huynh, Chloe Chose, Guston Zervoudakis, Bryan Clampitt, Sean Lapp, David Joyce, George Douglas Letson, Jonathan Metts, Odion Binitie, John E. Mullinax, Alexander Lazarides. Oncolytic Viral Therapy in Osteosarcoma. Viruses 2024; 16(7): 1139 doi: 10.3390/v16071139
|
| 46 |
Dushyant Singh Dahiya, Saurabh Chandan, Hassam Ali, Bhanu Siva Mohan Pinnam, Manesh Kumar Gangwani, Hashem Al Al Bunni, Andrew Canakis, Harishankar Gopakumar, Ishaan Vohra, Jay Bapaye, Mohammad Al-Haddad, Neil R. Sharma. Role of Therapeutic Endoscopic Ultrasound in Management of Pancreatic Cancer: An Endoscopic Oncologist Perspective. Cancers 2023; 15(12): 3235 doi: 10.3390/cancers15123235
|
| 47 |
Mason J. Webb, Ugur Sener, Richard G. Vile. Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma. Pharmaceuticals 2023; 16(6): 793 doi: 10.3390/ph16060793
|
| 48 |
Henry Sossa-Rojas, Pedro Gabriel Franco-Maz, Carlos Manuel Zapata-Acevedo, Carlos Arturo Guerrero-Fonseca. Cultivo de explantes de adenocarcinoma gástrico humano: Modelo para la evaluación de la actividad oncolítica del rotavirus Wt1-5. Revista de la Facultad de Medicina 2023; 71(3): e105765 doi: 10.15446/revfacmed.v71n3.105765
|
| 49 |
Daniel Meraviglia-Crivelli, Angelina Zheleva, Martin Barainka, Beatriz Moreno, Helena Villanueva, Fernando Pastor. Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System. Biomedicines 2022; 10(8): 1842 doi: 10.3390/biomedicines10081842
|
| 50 |
Supaporn Numpadit, Chiaki Ito, Takaaki Nakaya, Katsuro Hagiwara. Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma. Medical Oncology 2023; 40(5) doi: 10.1007/s12032-023-02002-z
|
| 51 |
Shiyu Liu, Fan Li, Li Deng, Qiongqiong Ma, Wenyi Lu, Zhuoqian Zhao, Huanzhen Liu, Yixuan Zhou, Manli Hu, Hui Wang, Yingbin Yan, Mingfeng Zhao, Hongkai Zhang, Mingjuan Du. Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. Molecular Therapy - Oncolytics 2023; 30: 275 doi: 10.1016/j.omto.2023.08.011
|
| 52 |
Francisca Cristi, Tomás Gutiérrez, Mary M. Hitt, Maya Shmulevitz. Genetic Modifications That Expand Oncolytic Virus Potency. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.831091
|
| 53 |
Aatiya Ahmad, Parvez Khan, Asad Ur Rehman, Surinder Kumar Batra, Mohd Wasim Nasser. Immunotherapy: an emerging modality to checkmate brain metastasis. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01818-7
|
| 54 |
Mingjing Deng, Qi Wang. Research Advances of Clinical Application of Oncolytic Viruses in Treatment
of Gynecologic Cancers. Current Cancer Drug Targets 2023; 23(7): 505 doi: 10.2174/1568009623666230221154415
|
| 55 |
Ryan Kilgore, Arianna Minzoni, Shriarjun Shastry, Will Smith, Eduardo Barbieri, Yuxuan Wu, Jacob P. LeBarre, Wenning Chu, Juliana O'Brien, Stefano Menegatti. The downstream bioprocess toolbox for therapeutic viral vectors. Journal of Chromatography A 2023; 1709: 464337 doi: 10.1016/j.chroma.2023.464337
|
| 56 |
Samagra Jain, Rahul A. Sheth. Modulating the tumor immune microenvironment with locoregional image-guided interventions. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1057597
|
| 57 |
M. Vindhya, M. N. Ramesh Bharadwaj, Kanthesh M. Basalingappa, T. S. Gopenath, Ashok Gnanasekaran. Targeted Cancer Therapy in Biomedical Engineering. Biological and Medical Physics, Biomedical Engineering 2023; : 179 doi: 10.1007/978-981-19-9786-0_5
|
| 58 |
Monika A. Papież, Wirginia Krzyściak. Biological Therapies in the Treatment of Cancer—Update and New Directions. International Journal of Molecular Sciences 2021; 22(21): 11694 doi: 10.3390/ijms222111694
|
| 59 |
Mason J. Webb, Thanich Sangsuwannukul, Jacob van Vloten, Laura Evgin, Benjamin Kendall, Jason Tonne, Jill Thompson, Muriel Metko, Madelyn Moore, Maria P. Chiriboga Yerovi, Michael Olin, Antonella Borgatti, Mark McNiven, Satdarshan P. S. Monga, Mitesh J. Borad, Alan Melcher, Lewis R. Roberts, Richard Vile. Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-49286-x
|
| 60 |
|
| 61 |
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan. mRNA vaccines for cancer immunotherapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1029069
|
| 62 |
Prathibha Ambegoda-Liyanage, Sophia R.-J. Jang. Resistance in oncolytic viral therapy for solid tumors. Applied Mathematics and Computation 2024; 469: 128546 doi: 10.1016/j.amc.2024.128546
|
| 63 |
Sangiliyandi Gurunathan, Pratheep Thangaraj, Lin Wang, Qilong Cao, Jin-Hoi Kim. Nanovaccines: An effective therapeutic approach for cancer therapy. Biomedicine & Pharmacotherapy 2024; 170: 115992 doi: 10.1016/j.biopha.2023.115992
|
| 64 |
Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, Yuan Chao Xue, Jingchun Zhang, Honglin Luo. A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice. Cancer Letters 2022; 548: 215849 doi: 10.1016/j.canlet.2022.215849
|
| 65 |
Firas Batrash, Adnan Shaik, Rayaan Rauf, Mahmoud Kutmah, Jun Zhang. Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic Strategies. Cancers 2024; 16(6): 1113 doi: 10.3390/cancers16061113
|
| 66 |
Gunjan Dagar, Ashna Gupta, Tariq Masoodi, Sabah Nisar, Maysaloun Merhi, Sheema Hashem, Ravi Chauhan, Manisha Dagar, Sameer Mirza, Puneet Bagga, Rakesh Kumar, Ammira S. Al-Shabeeb Akil, Muzafar A. Macha, Mohammad Haris, Shahab Uddin, Mayank Singh, Ajaz A. Bhat. Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04292-3
|
| 67 |
Daciana Elena Brănişteanu, Elena Porumb-Andrese, Vlad Porumb, Alexandra Stărică, Andreea Dana Moraru, Alin Codruț Nicolescu, Mihail Zemba, Cătălina Ioana Brănişteanu, George Brănişteanu, Daniel Constantin Brănişteanu. New Treatment Horizons in Uveal and Cutaneous Melanoma. Life 2023; 13(8): 1666 doi: 10.3390/life13081666
|
| 68 |
Isabela Granha, Gustavo Sartorelli, Oswaldo Keith Okamoto, Elisa Helena Farias Jandrey. Emergent and underexplored oncolytic viruses for treating pediatric central nervous system tumors. EJC Paediatric Oncology 2024; 3: 100151 doi: 10.1016/j.ejcped.2024.100151
|
| 69 |
Babak Arjmand, Sepideh Alavi-Moghadam, Golnar Khorsand, Maedeh Sarvari, Rasta Arjmand, Mostafa Rezaei-Tavirani, Mohsen Rajaeinejad, Reza Mosaed. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment. Regenerative Engineering and Translational Medicine 2024; doi: 10.1007/s40883-024-00338-0
|
| 70 |
G. V. R. K. Vithanage, Sophia R-J Jang. Optimal Immunotherapy of Oncolytic Viruses and Adopted Cell Transfer in Cancer Treatment. WSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE 2022; 19: 140 doi: 10.37394/23208.2022.19.15
|
| 71 |
Georgios M. Stergiopoulos, Ianko Iankov, Evanthia Galanis. Personalizing Oncolytic Immunovirotherapy Approaches. Molecular Diagnosis & Therapy 2024; 28(2): 153 doi: 10.1007/s40291-023-00689-4
|
| 72 |
Suyog Shaha, Danika Rodrigues, Samir Mitragotri. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation. Journal of Controlled Release 2024; 367: 737 doi: 10.1016/j.jconrel.2024.01.072
|
| 73 |
Xin Wang, Jia He, Minmin Sun, Shiwan Wang, Jinxiu Qu, Hanping Shi, Benqiang Rao. High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapy. Clinical and Translational Oncology 2024; doi: 10.1007/s12094-024-03553-x
|
| 74 |
Khandoker Usran Ferdous, Mulu Z. Tesfay, Aleksandra Cios, Randal S. Shelton, Conner Hartupee, Alicja Urbaniak, Jean Christopher Chamcheu, Michail N. Mavros, Emmanouil Giorgakis, Bahaa Mustafa, Camila C. Simoes, Isabelle R. Miousse, Alexei G. Basnakian, Omeed Moaven, Steven R. Post, Martin J. Cannon, Thomas Kelly, Bolni Marius Nagalo. Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. Biomedicines 2024; 12(7): 1596 doi: 10.3390/biomedicines12071596
|
| 75 |
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, Navneet Singh, Purvish Parikh, Bharti Bisht, Anubhab Mukherjee, Manash K. Paul. Lung cancer immunotherapy: progress, pitfalls, and promises. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01740-y
|
| 76 |
Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, Anthony K. Park, Sang-In Kim, Jianming Lu, Hannah Valencia, Yuman Fong, Yanghee Woo. Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients. International Journal of Molecular Sciences 2023; 24(18): 14189 doi: 10.3390/ijms241814189
|
| 77 |
Palaniyandi Muthukutty, Hyun Woo, Murali Ragothaman, So Yoo. Recent Advances in Cancer Immunotherapy Delivery Modalities. Pharmaceutics 2023; 15(2): 504 doi: 10.3390/pharmaceutics15020504
|
| 78 |
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, Hensin Tsao. Recent progress in cancer vaccines and nanovaccines. Biomaterials 2025; 314: 122856 doi: 10.1016/j.biomaterials.2024.122856
|
| 79 |
Kannan Raja. Comments on “Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses”. Oral Oncology 2024; 155: 106897 doi: 10.1016/j.oraloncology.2024.106897
|
| 80 |
Ted Kim, Nam Q. Bui. The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies. Cancers 2023; 15(6): 1692 doi: 10.3390/cancers15061692
|
| 81 |
Lin Fang, Weiping Tian, Chen Zhang, Xueyan Wang, Wanjing Li, Qi Zhang, Yuxin Zhang, Junnian Zheng. Oncolytic Adenovirus-Mediated Expression of CCL5 and IL12 Facilitates CA9-Targeting CAR-T Therapy Against Renal Cell Carcinoma. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4201217
|
| 82 |
Archita Rai, Swati G Deshpande, Ashish Vaidya, Raju K Shinde. Advancements in Immunotherapy for Breast Cancer: Mechanisms, Efficacy, and Future Directions. Cureus 2024; doi: 10.7759/cureus.68351
|